Follow-up duration and 30-day and 1-year mortality data for both
myocardial infarction per region
Patients were followed up for a total of 678 ± 431 days; all-cause
mortality data are summarised in Table 3 . All-cause mortality
rates for both sexes and both types of infarction were lower when PCI
was performed on the patient. In numerous cases, the analysis confirmed
more favourable mortality data in the WR. Regarding the STEMI group,
male patients and patients who underwent PCI, mortality was lowest in
the WR at both examined times (p = 0.03, p < 0.01). In female
patients of the same group—independent of treatment received (PCI vs.
no PCI)—mortality was lowest in the WR at both examined times; a
significant difference was only found in the 1-year mortality rate of
patients treated via PCI (p = 0.04).
No statistically significant differences were observed regarding the
30-day mortality rate of the NSTEMI group among the three regions;
however, the lowest values were detected in the ER in males and the WR
in females. At the 1-year checkpoint, females who underwent PCI in the
WR exhibited significantly lower mortality values than in the CR (p
< 0.01). Upon comparison between females in the STEMI and
NSTEMI groups at the 30-day checkpoint, mortality rate was higher in the
STEMI group than in the NSTEMI group. The mortality rate among males
showed no differences between the STEMI and NSTEMI groups; however, at
the 1-year checkpoint, the NSTEMI group had a higher mortality rate than
the STEMI group for both sexes (males vs. females, NSTEMI: 22.3% vs.
17.2%; STEMI; 28.2% vs. 26.1%).